Anti-GUCY2C CAR-T cells

Anti-GUCY2C CAR-T cells (合肥梧桐生物科技有限公司)

Report date: 2025/05/14 18:13:57

Base Information

Drug NameAnti-GUCY2C CAR-T cells

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-Heat-stable enterotoxin receptor

TargetsHeat-stable enterotoxin receptor

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesHeFei Parasol Biotech Co Ltd

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A